Position in INSM
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$97,684,229
-$4,416,508 QoQ
Shares Held
597,384
+1.8% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.45244599788411.ToString("F0")%
Shared 0.ToString("F0")%
None 0.5475540021158919.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Jun 30, 2020CallValue
$746,334
CallShares
27,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. INSM ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
This page
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in INSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $97,684,229 | 597,384 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $102,100,737 | 586,651 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $73,999,393 | 513,849 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $26,086,591 | 259,207 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,678,432 | 205,511 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,095,348 | 160,709 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,307,135 | 127,495 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $14,011,710 | 209,130 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,938,518 | 71,453 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,985,791 | 96,347 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,868,297 | 113,596 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,032,321 | 143,712 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,988,982 | 116,656 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $421,216 | 21,082 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $558,077 | 25,909 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $522,045 | 26,473 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,877,837 | 79,908 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,245,154 | 119,132 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,242,122 | 154,035 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,624,460 | 232,764 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,696,571 | 225,971 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,388,545 | 251,984 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $4,748,747 | 147,752 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $746,334 | 27,100 | Call | Defined | 2020-08-13 | |
| 2020-06-30 | $3,073,408 | 111,598 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,174,997 | 73,300 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||